Schedule 13G ownership disclosure

CTI BIOPHARMA CORP

Security class unavailable · CUSIP: 12648L106

Event date: 2018-01-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950103-18-001529
Form type
SC 13G/A
Filer
Baxalta Inc
CIK
CIK 1620546
Filed
Feb 05, 2018
Reporting period
Jan 01, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub